Ductal carcinomas in situ;Cancers canalaires in situ

Presse Medicale

Volumn 32, Issue 3, 2003, Pages 134-140

  De Roquancourt, Anne ^b   Cottu, Paul Henry ^b   Cuvier, Caroline ^b   Nowak, H ^b   Espie, Marc ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; ASPIRATION CYTOLOGY; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; HUMAN; MAMMOGRAPHY; MASTECTOMY; STEREOTAXIC SURGERY;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; RADIOTHERAPY DOSAGE; TAMOXIFEN; TIME FACTORS;

EID: 0037464779     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nowak H. Cancers canalaires in situ du sein. In: Espié M, Gorins A, eds. Le sein. Paris: ESKA, 2001.
2. Bassett LW. Imaging of breast masses. Radiol Clin North Am 2000; 38: 669-91.
3. Scarff W, Torloni H. Types histologiques des tumeurs du sein. Classification histologique internationale des tumeurs. Geneve: OMS, 1981 (vol 2).
4. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1989; 55: 231-73.
5. Lagios MD, Margolin FR, Westdahl PR, Rose M. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618-24.
6. Lagios MD, Westdahl PR, Margolin FR, Rose M. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50: 1309-14.
7. Holland R, Hendriks JH, Verbeek ALM, Mravunac M, Steckhoven HHS. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519-22.
8. Faverly DRG, Burgers L, Bult P, Holland R. Three dimensional Imaging of mammary ductal carcinoma in situ: clinical implication. Seminars in Diagnostic pathology 1994; 11: 193-8.
9. Azzlopardi J.-G. Problems in Breast Pathology. London: Saunders Co, 1979.
10. Bellamy COC, McDonald C, Salter DM et al. Non invasive ductal carcinoma of the breast. The relevance of histologic categorization. Human Pathol 1993; 24: 16-23.
11. Weiss MC, Fowble BE, Solin LJ, Yeh IT, Schultz DJ. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 1992; 23: 941-7.
12. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1992; 16: 1183-96.
13. Schwartz GF, Patchefsky AS, Finkelstein SD et al. Non palpable in situ ductal carcinoma of the breast: predictors of multicentry and microinvasion and implications for treatment. Arch Surg 1989; 124: 23-32.
14. Holland R, Peterse JL, Millis RR et al. Ductal carcinoma in situ: a proposal for anew classification. Semin Diagn Pathol 1994; 11: 167-80.
15. Silverstein MJ, Poller DM, Waisman JR et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154-7.
16. Silverstein MJ, Lagios MID, Craig PH et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 2267-74.
17. Silverstein MJ, Lagios MID, Groshen S et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999; 340: 1455-61.
18. Goldstein NS, Kestin L, Vicini F. Intraductal carcinoma of the breast. Am J Surg Pathol 2000; 24: 1058-67.
19. Consensus Conference on the Classification of Ductal. The Consensus Conference Comitee. Hum Pathol 1997; 28: 1221-5.
20. Silver SA, Tavassoli F. Mammary ductal carcinoma in situ with microinvasion. Cancer 1998; 82: 2382-90.
21. Schwartz GF, Olivotto IA, Ersnster VL, Pressman PI. The consensus conference on the treatment of in in situ ductal carcinoma of the breast. Human Pathol 1999; April: 22-5.
22. Fisher B, Dignam J, Wolmark N et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol 1998; 16: 441-52.
23. Fisher B, Dignam J, Wolmark N et al. Tamoxifin treatment of intraducal breast cancer: a national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet 1999; 353: 1993-2000.
24. Julien JP, Bijker N, Fentiman IS et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first reslults of the EORTC randomised phase III trial 10853. Lancet 2000; 355: 528-33.